| Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767) |
|---|
| 01/10/2008 | US20080009513 Therapeutic agents |
| 01/10/2008 | US20080009506 Imidazole Compound |
| 01/10/2008 | US20080009477 Arylalkyl Ureas As Cb1 Antagonists |
| 01/10/2008 | US20080008762 Steroid Formulation And Methods Of Treatment Using Same |
| 01/10/2008 | US20080008720 Substituted Tricyclic Heterocycles and their Uses |
| 01/10/2008 | US20080008662 Aerosol Drug Inhibition of Lung Cancer |
| 01/10/2008 | CA2660182A1 Dioxo-alkanes and dioxo-alkenes compounds |
| 01/10/2008 | CA2656851A1 Substituted cinnamoyl anthranilate compounds exhibiting anti-fibrotic activity |
| 01/10/2008 | CA2656757A1 Novel anologs of vasoactive intestinal peptide |
| 01/10/2008 | CA2656620A1 Cd20 binding molecules for the treatment of copd |
| 01/10/2008 | CA2656366A1 Combination of hmg-coa reductase inhibitors with phosphodiesterase 4 inhibitors for the treatment of inflammatory pulmonary diseases |
| 01/10/2008 | CA2655860A1 Method for the eradication of pathogens indluding s. aureus and antibiotic resistant microbes from the upper respiratory tract of mammals and for inhibiting the activation of immune cells |
| 01/09/2008 | EP1876239A1 Degranulation inhibitor |
| 01/09/2008 | EP1876179A1 Thienopyrimidone compound |
| 01/09/2008 | EP1875922A2 Intestinal trefoil proteins |
| 01/09/2008 | EP1875917A2 Use of NO for the treatment or prevention of reversible pulmonary vasoconstriction |
| 01/09/2008 | EP1875915A1 Therapeutic agent for chronic obstructive pulmonary disease |
| 01/09/2008 | EP1875913A1 Compositions and method for treating infection in cattle and swine |
| 01/09/2008 | EP1875907A2 Use of yessotoxins in the treatment of allergic and asthmatic processes |
| 01/09/2008 | EP1875906A2 Therapeutic use of yessotoxins as human tumor cell growth inhibitors |
| 01/09/2008 | EP1874788A1 Monosaccharide derivatives as anti-inflammatory and/or anti-cancer agents |
| 01/09/2008 | EP1874781A1 Dihydrothienopyrimidines for the treatment of inflammatory diseases |
| 01/09/2008 | EP1874727A1 New muscarinic receptor antagonists |
| 01/09/2008 | EP1874306A1 Compositions of an orally active 1,2,4-oxadiazole for nonsense mutation suppression therapy |
| 01/09/2008 | EP1874270A2 Pharmaceutical aerosol composition |
| 01/09/2008 | EP1608647B1 5-phenylthiazole derivatives and their use as p13 kinase inhibitors |
| 01/09/2008 | EP1527068B1 Novel arylimidazole derivatives, their use as no-syntase inhibitors and as modulators of sodium channels |
| 01/09/2008 | EP1400513B1 Unsymmetrical cyclic diamine compound |
| 01/09/2008 | EP1385845B1 N-aroyl cyclic amines |
| 01/09/2008 | EP1373218B1 Imidazolyl derivatives useful as histamine h3 receptor ligands |
| 01/09/2008 | EP1263730B1 Amine derivatives for the treatment of apoptosis |
| 01/09/2008 | EP1223935B1 Use of gemifloxacin compounds against bacteria |
| 01/09/2008 | EP1176956B1 Carboxylic acid derivatives that inhibit the binding of integrins to their receptors |
| 01/09/2008 | EP0866726B2 Pulmonary administration of dry powder alpha 1-antitrypsin |
| 01/09/2008 | CN101102773A Aminopyrazine analogs for treating glaucoma and other RHO kinase-mediated diseases |
| 01/09/2008 | CN101100689A Method for preparing pearl active peptide |
| 01/09/2008 | CN101100472A 4-amino-5,6-substituted thiopheno [2,3-D] pyrimidines compound and its uses |
| 01/09/2008 | CN101100434A Novel optical activity phenylethanolamine compounds and preparation method thereof |
| 01/09/2008 | CN101099864A Method for preparing inactivated vaccine both for preventing chicken Newcastle disease and infectious bronchitis |
| 01/09/2008 | CN101099863A Method for preparing triple inactivated vaccine for preventing chicken Newcastle disease, infectious bronchitis and egg drop syndrome |
| 01/09/2008 | CN101099849A Medicine for treating cold and its preparing process |
| 01/09/2008 | CN101099840A Medicine composition for treating pulmonary tuberculosis |
| 01/09/2008 | CN101099825A Lung heat-cleaning throat-moistening cough-relieving syrup |
| 01/09/2008 | CN101099804A Traditional Chinese medicine composition for treating sars caused by epidemic poison retention lung and preparation method thereof |
| 01/09/2008 | CN101099787A Traditional Chinese medicinal composition with remarkable wide-spectrum antiviral action |
| 01/09/2008 | CN101099782A Medicine for treating lung cancer and preparation technology thereof |
| 01/09/2008 | CN101099759A Compound traditional Chinese medicinal preparation for treating chronic laryngopharyngitis and its preparation method |
| 01/09/2008 | CN101099755A Medicine for treating allergic rhinitis and cold rhinitis |
| 01/09/2008 | CN101099730A Oral solid preparation containing ambroxol hydrochloride and guaifenesin active components |
| 01/09/2008 | CN101099729A Oral solid preparation containing ambroxol hydrochloride and salbutamol active components |
| 01/09/2008 | CN100360557C S protein of SARS virus, its vaccine and method for screening medicament using it |
| 01/09/2008 | CN100360532C Methods for the preparation of pyrrolotriazine compounds useful as kinase inhibitors |
| 01/09/2008 | CN100360521C 4,4-disubstituted piperidine derivatives having CCR3 antagonism |
| 01/09/2008 | CN100360499C Propanoic acid derivatives that inhibit binding of integrins to their receptors |
| 01/09/2008 | CN100360183C Method for the treatment of fibrosis using an antagonist of the integrin alpha-4 subunit |
| 01/09/2008 | CN100360182C Induction of antigen specific immunologic tolerance |
| 01/09/2008 | CN100360169C Hispid fig powder and its prepn process |
| 01/09/2008 | CN100360146C A Chinese medicine for treating rhinitis and preparation method thereof |
| 01/09/2008 | CN100360130C 1-(4-piperidinyl) benzimidazolones as histamine H3 antagonists |
| 01/09/2008 | CN100360129C Dehydro eleagnine derivative, its synthesizing method and use |
| 01/09/2008 | CN100360116C Powder formulations suitable for inhalation |
| 01/08/2008 | US7317102 Diarylmethyl and related compounds |
| 01/08/2008 | US7317089 Immunmoglobulin specific to tumor necrosis factor (ligand) superfamily, member 13b (tnfsf13b) protein for use in treatment and prevention of autoimmune, inflammatory, respiratory system, skin , blood and cell proliferative disorders |
| 01/08/2008 | US7317040 Nitric oxide synthase inhibitor phosphate salt |
| 01/08/2008 | US7317036 Prostaglandins for prostaglandin mediated diseases such as antihistamines |
| 01/08/2008 | US7317017 A2B adenosine receptor antagonists |
| 01/08/2008 | US7317014 pyrimidine derivatives such as 4-Chloro-5,6-diphenyl-2-(trifluoromethyl)pyrimidine, used for the treatment of inflammation and immunological diseases |
| 01/08/2008 | US7317011 Method of treating peripheral neuropathy |
| 01/08/2008 | US7317007 Such as 4-(4-Methoxy-7-morpholin-4-yl-benzothiazol-2-ylcarbamoyl)-piperidine-1-carboxylic acid tert-butyl ester; for prevention of illnesses based on the modulation of the adenosine system, such as Alzheimer's disease, Parkinson's disease, neuroprotection, schizophrenia, anxiety, pain |
| 01/08/2008 | US7316818 Liposome drug delivery of polycyclic, aromatic, antioxidant or anti-inflammatory compounds |
| 01/08/2008 | CA2414311C Pyrrolidine derivatives as inhibitors of endothelin-converting enzyme |
| 01/08/2008 | CA2389170C A process for the production of epinastine hydrochloride in the high-melting crystal modification |
| 01/08/2008 | CA2277877C Nitric oxide synthase inhibitors |
| 01/03/2008 | WO2008002449A2 Glycomimetic inhibitors of siglec-8 |
| 01/03/2008 | WO2008002246A1 A pharmaceutical composition comprising an ikk2 inhibitor and a second active ingrdient. |
| 01/03/2008 | WO2008001930A1 Pyridylisoxazole derivative |
| 01/03/2008 | WO2008001929A1 Treatment agent for inflammatory bowel disease |
| 01/03/2008 | WO2008001752A1 Treatment of chronic obstructive pulmonary disease by statin |
| 01/03/2008 | WO2008001079A1 Methods for identifying modulators of eoxin formation |
| 01/03/2008 | WO2008001055A1 Polyether polyols for use in the treatment and/or prevention of inflammatory lung disease |
| 01/03/2008 | WO2008000839A1 Quinolinone derivatives and their pharmaceutical compositions |
| 01/03/2008 | WO2008000483A2 Phenol derivatives for the treatment of respiratory diseases |
| 01/03/2008 | WO2007118198A3 2-METHYLENE-1α,25-DIHYDROXY-19,21-DINORVITAMIN D3 ANALOGS AND USES THEREOF |
| 01/03/2008 | WO2007113698A3 Preventative treatment and remission of allergic diseases |
| 01/03/2008 | US20080004317 Compounds |
| 01/03/2008 | US20080004312 Pyridine, pyrimidine, quinoline, quinazoline, and naphthalene urotensin-II receptor antagonists |
| 01/03/2008 | US20080004296 Organic Compounds |
| 01/03/2008 | US20080004295 Novel compounds |
| 01/03/2008 | US20080004294 Heterocyclic compounds |
| 01/03/2008 | US20080004293 Adenosine receptor antagonists and methods of making and using the same |
| 01/03/2008 | US20080004292 Substituted 8-[6-amino-3-pyridyl]xanthines |
| 01/03/2008 | US20080003290 Phenethanolamine Derivatives for Treatment of Respiratory Diseases |
| 01/03/2008 | US20080003221 Compositions and methods for treating inflammatory lung disease |
| 01/03/2008 | US20080003218 Anti-IgE antibodies |
| 01/03/2008 | US20080000473 pH-Based Methods and Devices for Preventing Hemagglutinin Cell Membrane Fusion |
| 01/03/2008 | DE3890998B4 Neutrophilenaktivierungsfaktor, Verfahren zu seiner Herstellung und ihn enthaltende pharmazeutische Zusammensetzung Neutrophilenaktivierungsfaktor, process for its preparation and pharmaceutical composition containing it |
| 01/03/2008 | DE102006030164A1 Inhalative Pulver Inhalation powder |
| 01/03/2008 | CA2656159A1 Pyridylisoxazole derivatives |
| 01/03/2008 | CA2655999A1 Treating agent of inflammatory bowel disease |
| 01/03/2008 | CA2654801A1 Quinolinone derivatives and their pharmaceutical compositions |